Alebund-B Reports No Share Capital Changes in October; Public Float Meets 19.53% Requirement

Bulletin Express11-04

Alebund Pharmaceuticals (Jiangsu) Limited (Alebund-B) disclosed its Monthly Return for Equity Issuer for the period ended 31 October 2026, confirming that both authorised (registered) and issued share capital remained unchanged during the month.

The company’s registered share capital stood at RMB 348.37 million, divided into: • 235.64 million H shares listed on the Hong Kong Stock Exchange, each with a par value of RMB 1. • 112.73 million unlisted ordinary shares, also with a par value of RMB 1.

Issued share capital mirrored the registered figures, with 235.64 million H shares and 112.73 million unlisted shares outstanding. No new shares were issued, and no treasury shares were held or cancelled in October.

Alebund-B confirmed compliance with the Hong Kong Main Board’s public-float rules: at least 19.53% of its H-share class remained in public hands as of month-end.

The company reported no movements involving share options, warrants, convertible securities, or other arrangements to issue additional shares during the month. Chen Nanyou, Joint Company Secretary, submitted the filing on 4 November 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment